Balancing Cancer Immunotherapy Efficacy and Toxicity

Anti–programmed cell death-1 receptor/programmed cell death-1 receptor ligand–directed therapies are transforming cancer care, with durable antitumor responses observed in multiple cancer types. Toxicities arising from therapy are autoimmune in nature and may affect essentially any organ system. The...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Johnson, Douglas B., Jakubovic, Baruch D., Sibaud, Vincent, Sise, Meghan E.
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: American Academy of Allergy, Asthma & Immunology 2020
Aiheet:
Review and Feature Article
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Samankaltaisia teoksia